Cargando...
Biomarkers for the Early Detection and Progression of Alzheimer’s Disease
The recent failures of potential disease-modifying drugs for Alzheimer’s disease (AD) may reflect the fact that the enrolled participants in clinical trials are already too advanced to derive a clinical benefit. Thus, well-validated biomarkers for the early detection and accurate diagnosis of the pr...
Guardado en:
| Publicado en: | Neurotherapeutics |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233625/ https://ncbi.nlm.nih.gov/pubmed/27738903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0481-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|